Spontaneous but not experimental metastatic activities differentiate primary tumor-derived vs metastasis-derived mouse prostate cancer cell lines

Clinical and Experimental Metastasis

Volumn 15, Issue 6, 1997, Pages 630-638

  Hall, Simon J ^a   Thompson, Timothy C ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Metastasis; Orthotopic mouse model; Prostate cancer

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PROSTATE CANCER; TUMOR GROWTH;

ANIMALS; DISEASE MODELS, ANIMAL; LUNG NEOPLASMS; MALE; MICE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030880985     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018499515883     Document Type: Article

References (39)

1. Parker SL, Tong T, Bolden S and Wingo PA, 1996, Cancer statistics, 1996. CA Cancer J Clin, 65, 5-27.
2. Scardino PT, 1989, Early detection of prostate cancer. Urol Clin N Am, 16, 635-55.
3. Epstein JL, Walsh PC, Carmichael M and Brendler C, 1994, Pathological and clinical findings to predict tumor extent of non-palpable (state Tlc) prostate cancer. JAMA, 271, 368-74.
4. Ohori M, Wheeler TM, Kattan MW, Goto Y and Scardino PT, 1995, Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol. 154, 1818-24.
5. Zeitman AL, Edelstein RA, Coen JJ, Bahayan RK and Krane RJ, 1994, Radical prostatectomy for adenocarcinoma of the prostate: the influence of preoperative and pathologic findings on biochemical disease-free outcome. Urology, 43, 828-33.
6. Sakr WA, Macoska JA, Benson PD, Grignon DJ, Wolman SR, Pontes JE and Crissman JD, 1994, Allelic loss in locally metastatic, multisampled prostate cancer. J Urol, 54, 3273-79.
7. Qian J, Bostwick DG, Takashi S, Borell TJ, Herath JF, Lieber MM and Jenkins RB, 1995, Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res, 55, 5408-14.
8. Mirchandani D, Zheng J, Miller GJ, Ghosh AK, Shibata DK, Cote RJ and Roy-Burman P, 1995, Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer. Am J Path, 147, 92-101.
9. Thompson TC, Timme TL and Sehgal I, 1997, Oncogenes, growth factors and hormones in prostate cancer. In: Dickson RB and Salomon DS, eds. Hormones and Growth Factors in Development and Neoplasia. New York: John Wiley, in press.
10. Thompson TC, Timme TL and Sehgal I, 1997, The role of p53 in prostate cancer progression. In: Fortner JG and Sharp PA, eds. Accomplishments in Cancer Research 1996. Philadelphia: Lippincott-Raven, in press.
11. Bottazzi B, Mantovani G, Taraboletti G and Giavazzi R, 1986, Characterization of spontaneous metastases from autochthonous 3-methylchlanthrene-induced tumors. Invasion Metastasis, 6, 44-57.
12. Price JE, Carr D and Tarin D, 1984, Spontaneous and induced metastasis of naturally occurring tumors in mice: analysis of cell shedding into the blood. J Natl Cancer Inst, 73, 1319-26.
13. Kripke ML, Gruys E and Fidler IJ, 1978, Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent origin. Cancer Res, 38, 2962-7.
14. Giavazzi R, Alessandri G, Spreafico F, Garattini S and Mantovani A, 1980, Metastasizing capacity of tumor cells from spontaneous metastases of transplanted murine tumors. Br J Cancer, 42, 462-72.
15. Eceles SA, Heckford SE and Alexander P, 1980, Effect of cyclosporin A on the growth and spontaneous metastasis of syngeneic animal tumours. Br J Cancer, 42, 252-9.
16. Mantovani A, Giavazzi R, Alessandri G, Spreafico F and Garattini S, 1981, Characterization of tumor lines derived from spontaneous metastases of a transplanted murine sarcoma. Eur J Cancer, 17, 71-6.
17. Stackpole CW, 1981, Distinct lung-colonizing and lung-metastasizing cell populations in B16 mouse melanoma. Nature, 289, 798-800.
18. Talmadge JE and Fidler IJ, 1982, Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors. J Natl Cancer Inst, 69, 975-80.
19. Sweeney FL, Pot-Deprun J, Poupon M-F and Chouroulinkov I, 1982, Heterogeneity of the growth and metastatic behavior of cloned cell lines derived from a primary rhabdomyosarcoma. Cancer Res, 42, 3776-82.
20. Weiss L, Mayhew E, Glaves Rapp D and Holmes JC, 1982, Metastatic inefficiency in mice bearing B16 melanomas. Br J Cancer, 45, 44-53.
21. Neri A, Welch D, Kawaguchi T and Nicolson GL, 1982, Development and biological properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. J Natl Cancer Inst, 68, 507-15.
22. Talmadge JE and Fidler IJ, 1982, Cancer metastasis is selective or random depending on the parent population. Nature, 297, 593-4.
23. Weiss L, Holmes JC and Ward PM, 1983, Do metastases arise from pre-existing subpopulations of cancer cells. Br J Cancer, 47, 81-9.
24. Welch DR, Neri A and Nicolson GL, 1983, Comparison of 'spontaneous' and 'experimental' metastasis using rat 13762 mammary adenocarcinoma metastatic cell clones. Invasion Metastasis, 3, 65-80.
25. Miller FR, Miller BE and Heppner GH, 1983, Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumor: heterogeneity in phenotypic stability. Invastion Metastasis, 3, 22-31.
26. Thompson TC, Southgate J, Kitchener G and Land H, 1989, Multi-stage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell, 56, 917-30.
27. Merz VW, Miller GJ, Krebs T, et al. 1991, Elevated TGF-β1 and β3 mRNA levels are associated with ras and myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression. Molec Endocr, 5, 503-13.
28. Thompson TC, Timme TL, Kadmon D, Park SH, Egawa S and Yoshida K, 1993, Genetic predisposition and mesenchymal-epithelial interactions in ras + myc-induced carcinogenesis in reconstituted mouse prostate. Molec Carcinog, 7, 165-79.
29. Thompson TC, Park SH, Timme TL et al. 1995, Loss of p53 function leads to metastasis in ras + myc-initiated mouse prostate cancer. Oncogene, 10, 869-79.
30. Sehgal I, Baley PA and Thompson TC, 1996, Transforming growth factor β1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro. Cancer Res. 56, 3359-65.
31. Baley PA, Yoshida K, Qian W, Sehgal I and Thompson TC, 1995, Progression to androgen insensitivity in a novel in vitro mouse model for prostate cancer. J Steroid Biochem Molec Biol, 52, 403-13.
32. Janik P, Briand P and Hartmann NR, 1975, The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors. Cancer Res, 35, 3698-704.
33. Fu X, Herrera H and Hoffman RM, 1992, Ortholopic growth and metastasis of human prostate carcinoma in nude mice after transplantation of histologically intact tissue. Int J Cancer, 52, 987-90.
34. Pettaway CA, Stephenson R and Fidler IJ, 1993, Development of orthotopic models of metastatic human prostate cancer. Cancer Bull, 45, 424-9.
35. Isaacs JT, 1997, The R-3327 system of rat prostatic cancers. Urol Oncol, 2, 99-128.
36. Thompson TC, 1990, Growth factors and oncogenes in prostate cancer. Cancer Cells, 2, 345-54.
37. Thompson TC, Timme TL, Hall SJ and Stapleton AMF, 1996, Perspectives on the molecular biology of prostate cancer. In: Vogelzang NJ, Scardino PT, Shipley WU and Coffey DS, eds. Comprehensive Textbook of Genitourinary Oncology, Baltimore: Williams & Wilkins, pp. 593-9.
38. Fidler IJ, 1990, Critical factors in the biology of human cancer metastasis: twenty-eighth GHA Clowes memorial lecture. Cancer Res, 50, 6130-8.
39. Manzotti C, Audisio RA and Pratesi G, 1993, Importance of orthotopic implantation for human tumors as model systems: relevance to metastasis and invasion. Clin Exp Metastasis, 11, 5-14.